NO923637L - Fremgangsmaate for fremstilling av klorsulfat- og sulfamatderivater av 2,3:4,5-bis-0-(1-metyletyliden)-beta-d-fruktopyranose og (1-metylcykloheksyl)metanol - Google Patents

Fremgangsmaate for fremstilling av klorsulfat- og sulfamatderivater av 2,3:4,5-bis-0-(1-metyletyliden)-beta-d-fruktopyranose og (1-metylcykloheksyl)metanol

Info

Publication number
NO923637L
NO923637L NO92923637A NO923637A NO923637L NO 923637 L NO923637 L NO 923637L NO 92923637 A NO92923637 A NO 92923637A NO 923637 A NO923637 A NO 923637A NO 923637 L NO923637 L NO 923637L
Authority
NO
Norway
Prior art keywords
fructopyranose
beta
bis
methanol
methylycylohexyl
Prior art date
Application number
NO92923637A
Other languages
English (en)
Other versions
NO179284C (no
NO179284B (no
NO923637D0 (no
Inventor
Cynthia A Maryanoff
Lorraine Scott
Kirk L Sorgi
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of NO923637D0 publication Critical patent/NO923637D0/no
Publication of NO923637L publication Critical patent/NO923637L/no
Publication of NO179284B publication Critical patent/NO179284B/no
Publication of NO179284C publication Critical patent/NO179284C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/34Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfuric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO923637A 1991-09-19 1992-09-18 Fremgangsmåte for fremstilling av klorsulfat- og sulfamatderivatene av 2,3:4,5-bis-0-(1-metyletyliden)--D-fruktopyranose og (1-metylcykloheksyl)metanol NO179284C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76272091A 1991-09-19 1991-09-19
US92626992A 1992-08-05 1992-08-05

Publications (4)

Publication Number Publication Date
NO923637D0 NO923637D0 (no) 1992-09-18
NO923637L true NO923637L (no) 1993-03-22
NO179284B NO179284B (no) 1996-06-03
NO179284C NO179284C (no) 1996-09-11

Family

ID=27117178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923637A NO179284C (no) 1991-09-19 1992-09-18 Fremgangsmåte for fremstilling av klorsulfat- og sulfamatderivatene av 2,3:4,5-bis-0-(1-metyletyliden)--D-fruktopyranose og (1-metylcykloheksyl)metanol

Country Status (23)

Country Link
US (1) US5387700A (no)
EP (1) EP0533483B1 (no)
JP (1) JP3174410B2 (no)
KR (1) KR100229180B1 (no)
CN (1) CN1035820C (no)
AT (1) ATE163937T1 (no)
AU (1) AU651244B2 (no)
CA (1) CA2078519C (no)
DE (1) DE69224691T2 (no)
DK (1) DK0533483T3 (no)
EG (1) EG20164A (no)
ES (1) ES2114917T3 (no)
FI (1) FI107731B (no)
GR (1) GR3026618T3 (no)
HU (1) HU212634B (no)
IL (1) IL103172A (no)
MX (1) MX9205305A (no)
MY (1) MY113564A (no)
NO (1) NO179284C (no)
NZ (1) NZ244409A (no)
PH (1) PH31291A (no)
TW (1) TW217413B (no)
ZW (1) ZW14792A1 (no)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3250777B2 (ja) * 1995-02-13 2002-01-28 セントラル硝子株式会社 イミド類、その塩類およびそれらの製造法
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP2002539088A (ja) * 1999-02-17 2002-11-19 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 本態性振せんを処置するのに有用な抗痙攣性誘導体
US6420369B1 (en) 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
CA2415093A1 (en) * 2000-07-07 2002-01-17 Carlos Plata-Salaman Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
EP1309325A1 (en) 2000-08-02 2003-05-14 Ortho-McNeil Pharmaceutical, Inc. Anticonvulsant derivatives useful for the treatment of depression
PT1333887E (pt) 2000-10-30 2006-10-31 Ortho Mcneil Pharm Inc Metodo de tratamento de desordens musculares
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
WO2003039563A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
RU2004126093A (ru) * 2002-02-26 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CA2494233A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
CN100430408C (zh) * 2002-10-31 2008-11-05 奥索-麦克尼尔药品公司 制备吡喃果糖氨基磺酸酯衍生物的连续法
US7196209B2 (en) * 2002-10-31 2007-03-27 Ortho-Mcneil Pharmaceutical, Inc. Continuous process for the preparation of fructopyranose sulfamate derivatives
UA81657C2 (ru) * 2003-03-04 2008-01-25 Орто-Макнейл Фармасьютикел, Инк. Способ получения противосудорожных производных топирамата
WO2004108732A1 (en) * 2003-05-12 2004-12-16 Sun Pharmaceutical Industries Limited PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE
US20050058707A1 (en) * 2003-08-06 2005-03-17 Iran Reyes Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
MXPA06002067A (es) * 2003-08-22 2006-08-11 Johnson & Johnson Suministro gradual de topiramato durante periodo prolongado.
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
AU2004291081A1 (en) * 2003-11-14 2005-06-02 Alza Corporation Controlled release of topirimate in liquid dosage forms
KR20050062976A (ko) * 2003-12-19 2005-06-28 일동제약주식회사 2,3:4,5-비스-오-(1-메틸에틸리덴)-베타-디-프럭토피라노즈설파메이트의 새로운 개량된 제조방법
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701706A2 (en) * 2003-12-29 2006-09-20 Alza Corporation Novel drug compositions and dosage forms
MXPA06007510A (es) * 2003-12-29 2009-06-10 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas de topiramato.
US20050203287A1 (en) * 2004-03-11 2005-09-15 Chandrasekhar Batchu Process for the preparation of sulfamate derivatives
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
DE602005008084D1 (de) * 2004-08-24 2008-08-21 Janssen Pharmaceutica Nv Als antikonvulsive mittel geeignete neue benzokondensierte heteroarylsulfamidderivate
MX364884B (es) * 2004-10-05 2019-05-10 Fallbrook Intellectual Property Company Llc Star Transmisión continuamente variable.
KR20080012360A (ko) * 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
EP1888030A1 (en) * 2005-05-25 2008-02-20 Janssen Pharmaceutica N.V. Pediatric formulation of topiramate
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070191449A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US20070191459A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
US20070191453A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2007108009A1 (en) * 2006-03-17 2007-09-27 Alembic Limited A process for purification of topiramate
EA200870556A1 (ru) * 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
EP2142826B1 (en) * 2007-04-24 2015-10-28 Fallbrook Intellectual Property Company LLC Electric traction drives
CN101450951B (zh) * 2007-11-30 2012-10-10 重庆凯林制药有限公司 托吡酯的制备方法
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8748594B2 (en) 2010-02-05 2014-06-10 Scinopharm Taiwan, Ltd. Process for the preparation and purification of topiramate
CN102936268A (zh) * 2012-11-13 2013-02-20 江苏吉贝尔药业有限公司 一种托吡酯中间体丙酮叉的制备方法
CN106397502A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种托吡酯的合成工艺
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法
CN110655541A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯晶型
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN114350340B (zh) * 2022-01-13 2023-01-17 陕西科技大学 一种压裂用增渗剂及其制备方法和应用
WO2025049333A2 (en) * 2023-08-25 2025-03-06 University Of Iowa Research Foundation Therapeutic compounds and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol

Also Published As

Publication number Publication date
AU651244B2 (en) 1994-07-14
HU212634B (en) 1996-09-30
EP0533483A3 (en) 1994-11-02
MY113564A (en) 2002-04-30
FI924189L (fi) 1993-03-20
GR3026618T3 (en) 1998-07-31
NO179284C (no) 1996-09-11
TW217413B (no) 1993-12-11
FI107731B (fi) 2001-09-28
JPH05230011A (ja) 1993-09-07
CN1075317A (zh) 1993-08-18
EP0533483A2 (en) 1993-03-24
CN1035820C (zh) 1997-09-10
NZ244409A (en) 1995-02-24
AU2451892A (en) 1993-03-25
ES2114917T3 (es) 1998-06-16
IL103172A0 (en) 1993-02-21
KR100229180B1 (ko) 1999-11-01
CA2078519A1 (en) 1993-03-20
KR930006029A (ko) 1993-04-20
DE69224691T2 (de) 1998-08-20
FI924189A0 (fi) 1992-09-18
ATE163937T1 (de) 1998-03-15
EP0533483B1 (en) 1998-03-11
US5387700A (en) 1995-02-07
MX9205305A (es) 1993-07-01
HUT63612A (en) 1993-09-28
EG20164A (en) 1997-08-31
ZW14792A1 (en) 1994-04-20
HU9202974D0 (en) 1992-11-30
DE69224691D1 (de) 1998-04-16
IL103172A (en) 1997-01-10
DK0533483T3 (da) 1998-09-28
PH31291A (en) 1998-07-06
JP3174410B2 (ja) 2001-06-11
NO179284B (no) 1996-06-03
CA2078519C (en) 2003-09-16
NO923637D0 (no) 1992-09-18

Similar Documents

Publication Publication Date Title
NO923637L (no) Fremgangsmaate for fremstilling av klorsulfat- og sulfamatderivater av 2,3:4,5-bis-0-(1-metyletyliden)-beta-d-fruktopyranose og (1-metylcykloheksyl)metanol
MY129994A (en) Novel siloxane derivatives, producing method thereof and agents including siloxane derivative
ATE220416T1 (de) Organopolysiloxanhaltige zusammensetzungen auf wasserbasis, verfahren zu deren herstellung sowie deren verwendung
BR9607149A (pt) Produção e recuperação de éter dimetílico a partir de metanol
EP0616906A3 (en) Process for producing a decorative film.
FR2463170B1 (fr) Revetement anti-adhesif issu d'une composition durcissable par rayons uv et son procede d'obtention
FI906006A7 (fi) Menetelmä vaahtomuovien valmistamiseksi
FR2661872B1 (fr) Procede de fabrication d'un pare-soleil recouvert de tissu.
DK0451094T3 (da) Fremgangsmåde til fremstilling af pigmenter
EP0679039A3 (en) Process for the production of a television receiver.
DE69002765D1 (de) Verfahren zur herstellung eines deckenpaneels.
ATE142649T1 (de) Alkenylmethylhydroxypropylcelluloseether und ein verfahren zu ihrer herstellung
FR2691833B1 (fr) Méthode de production d'un dispositif électronique du type lamifié.
PL295277A1 (en) Method of obtaining 7-alpha-aminoacyl cephalosporines
ATE112563T1 (de) Diglycidyläther.
DE69107956D1 (de) Verfahren zur Herstellung eines Plastikschaumes.
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
DE69409800D1 (de) Verfahren zur herstellung von halogenierten alkoholen
DE69503106D1 (de) Verfahren zur Herstellung von L-Ascorbinsäure
IT7829321A0 (it) Processo pert la preparazione di un copolimero di esteri vinilici.
ATE182140T1 (de) Optisch aktive 1,4-dihydropyridinderivate sowie verfahren zu ihrer herstellung
ATE115975T1 (de) Verfahren zur herstellung von epoxyharzen, die aliphatisches, nicht hydrolysierbares chlorid enthalten.
FI925759A7 (fi) Klordioxidprocess baserad pao metanol
ATE156131T1 (de) Verbessertes verfahren zur herstellung von 2- amino(2,3,5-tri-o-benzyl-beta-d- arabinofuranosyl)adenin
EP0637776A4 (en) PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING A RELIEF CONFIGURATION FROM THIS COMPOSITION.

Legal Events

Date Code Title Description
MK1K Patent expired